Quantum BioPharma is trading at $4.30, up 10.82%, with Unbuzzd Wellness’s CEO appointment appearing to be the clearest company-specific catalyst. - The licensee appointed Michael Zapolin CEO on September 24, 2026. - His mandate includes financing, pursuing a stock-market listing, and executing a nationwide U.S. commercial rollout. - The gain came despite broader biotechnology weakness and softer major indexes.